Li Jinxiang, Zeng Qi
Department of Ophthalmology, First Hospital Affiliated with Hunan Normal University (Hunan Provincial People's Hospital), Changsha 410005, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1561-1571. doi: 10.11817/j.issn.1672-7347.2023.230108.
Glaucoma is a leading cause of irreversible blindness, and effective therapies to reverse the visual system damage caused by glaucoma are still lacking. Recently, the stem cell therapy enable the repair and regeneration of the damaged retinal neurons, but challenges regarding the source of stem cells remain. This study aims to investigate a protocol that allows the dedifferentiation of Müller cells into retinal stem cells, following by directed differentiation into retinal ganglion cells with high efficiency, and to provide a new method of cellular acquisition for retinal stem cells.
Epidermal cell growth factor and fibroblast growth factor 2 were used to induce the dedifferentiation of rat retinal Müller cells into retinal neural stem cells. Retinal stem cells derived from Müller cells were infected with a Trim9 overexpression lentiviral vector (PGC-FU-Trim9-GFP), and the efficiency of viral infection was assessed by fluorescence microscopy and flow cytometry. Retinoic acid and brain-derived neurotrophic factor treatments were used to induce the differentiation of the retinal stem cells into neurons and glial cells with or without the overexpression of Trim9. The expressions of each cellular marker (GLAST, GS, rhodopsin, PKC, HPC-1, Calbindin, Thy1.1, Brn-3b, Nestin, Pax6) were detected by immunofluorescence, PCR/real-time RT-PCR or Western blotting.
Rat retinal Müller cells expressed neural stem cells markers (Nestin and Pax6) with the treatment of epidermal cell growth factor and fibroblast growth factor 2. The Thy1.1 positive cell rate of retinal stem cells overexpressing Trim9 was significantly increased, indicating their directional differentiation into retinal ganglion cells after treatment with retinoic acid and brain-derived neurotrophic factor.
In this study, rat retinal Müller cells are dedifferentiated into retinal stem cells successfully, and Trim9 promotes the directional differentiation from retinal stem cells to retinal ganglion cells effectively.
青光眼是不可逆性失明的主要原因,目前仍缺乏有效逆转青光眼所致视觉系统损伤的治疗方法。近年来,干细胞疗法能够修复和再生受损的视网膜神经元,但干细胞来源问题依然存在挑战。本研究旨在探索一种方案,使穆勒细胞去分化为视网膜干细胞,随后高效定向分化为视网膜神经节细胞,并为视网膜干细胞提供一种新的细胞获取方法。
采用表皮细胞生长因子和成纤维细胞生长因子2诱导大鼠视网膜穆勒细胞去分化为视网膜神经干细胞。用Trim9过表达慢病毒载体(PGC-FU-Trim9-GFP)感染源自穆勒细胞的视网膜干细胞,通过荧光显微镜和流式细胞术评估病毒感染效率。使用视黄酸和脑源性神经营养因子处理,诱导视网膜干细胞在有无Trim9过表达的情况下分化为神经元和神经胶质细胞。通过免疫荧光、PCR/实时逆转录PCR或蛋白质印迹法检测各细胞标志物(GLAST、GS、视紫红质、PKC、HPC-1、钙结合蛋白、Thy1.1、Brn-3b、巢蛋白、Pax6)的表达。
经表皮细胞生长因子和成纤维细胞生长因子2处理后,大鼠视网膜穆勒细胞表达神经干细胞标志物(巢蛋白和Pax6)。过表达Trim9的视网膜干细胞中Thy1.1阳性细胞率显著增加,表明在用视黄酸和脑源性神经营养因子处理后它们定向分化为视网膜神经节细胞。
在本研究中,大鼠视网膜穆勒细胞成功去分化为视网膜干细胞,且Trim9有效促进了视网膜干细胞向视网膜神经节细胞的定向分化。